Literature DB >> 25362717

Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations.

Alexis Ogdie1, Sergio Schwartzman1, Lihi Eder1, Ajesh B Maharaj1, Devy Zisman1, Siba P Raychaudhuri1, Soumya M Reddy1, Elaine Husni2.   

Abstract

Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis that can lead to decreased health-related quality of life and permanent joint damage leading to functional decline. In addition to joint and skin manifestations, both psoriasis and PsA are associated with numerous comorbidities and extraarticular/cutaneous manifestations, which may influence the physician's choice of therapy. The objectives of this review are (1) to identify comorbidities in patients with PsA based on the available evidence; (2) to examine the effects of these comorbidities or extraarticular/cutaneous manifestation on the management of patients with PsA as well as the selection of therapy; and (3) to highlight research needs around comorbidities and treatment paradigms. This review is part of a treatment recommendations update initiated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

Entities:  

Keywords:  AUTOIMMUNE OPHTHALMIC DISEASE; CARDIOVASCULAR DISEASE; DIABETES; METABOLIC SYNDROME; OBESITY; OSTEOPOROSIS

Mesh:

Year:  2014        PMID: 25362717     DOI: 10.3899/jrheum.140882

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  18 in total

1.  Addressing comorbidities in psoriatic disease.

Authors:  Priya Patel; Cheryl F Rosen; Vinod Chandran; Yang Justine Ye; Dafna D Gladman
Journal:  Rheumatol Int       Date:  2017-11-28       Impact factor: 2.631

Review 2.  Atherosclerosis in psoriatic disease: latest evidence and clinical implications.

Authors:  Lihi Eder; Dafna D Gladman
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-10       Impact factor: 5.346

Review 3.  Making the next steps in psoriatic arthritis management: current status and future directions.

Authors:  Diviya Sritheran; Ying Ying Leung
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-10       Impact factor: 5.346

4.  Gastrointestinal comorbidities in patients with psoriatic arthritis.

Authors:  Ariel Zohar; Arnon Dov Cohen; Haim Bitterman; Ilan Feldhamer; Sari Greenberg-Dotan; Idit Lavi; Doron Comanesther; Erez Batat; Devy Zisman
Journal:  Clin Rheumatol       Date:  2016-08-17       Impact factor: 2.980

Review 5.  Psoriatic arthritis in Africa.

Authors:  Ajesh B Maharaj; Adewale Adebajo
Journal:  Clin Rheumatol       Date:  2021-06-28       Impact factor: 2.980

Review 6.  Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations.

Authors:  Laure Gossec; Laura C Coates; Maarten de Wit; Arthur Kavanaugh; Sofia Ramiro; Philip J Mease; Christopher T Ritchlin; Désirée van der Heijde; Josef S Smolen
Journal:  Nat Rev Rheumatol       Date:  2016-11-10       Impact factor: 20.543

7.  Management of psoriatic arthritis in rheumatology and dermatology settings: sub-analysis of the Italian population from the international LOOP study.

Authors:  Ennio Lubrano; Andrea Delle Sedie; Marco Romanelli; Maria Sole Chimenti; Luca Bianchi; Stefano Piaserico; Catia De Felice; Dario Graceffa; Maria Ilenia De Andres; Salvatore Curatolo; Rosa Daniela Grembiale; Stefano Dastoli; Chiara Arcuri; Rosa Giuseppa Angileri; Francesca Prignano; Francesca Bandinelli; Elena Baldissera; Santo Raffaele Mercuri; Chiara Franchi; Matteo Longhi; Angela Patrì; Francesco Caso; Giuseppe Passiu; Maria Antonia Montesu; Simone Parisi; Elena Stroppiana; Genoveffa Scotto di Luzio; Giovanni Italiano; Sergio Di Nuzzo; Daniele Santilli; Laura Bigi; Federica Lumetti; Concetto Paolo Agnusdei; Maria Grazia Ferrucci; Giuliana Gualberti; Francesca Marando; Roberta Ramonda; Francesco Cusano
Journal:  Clin Rheumatol       Date:  2020-11-06       Impact factor: 2.980

Review 8.  Psoriasis comorbidities: complications and benefits of immunobiological treatment.

Authors:  André Vicente Esteves de Carvalho; Ricardo Romiti; Cacilda da Silva Souza; Renato Soriani Paschoal; Laura de Mattos Milman; Luana Pizarro Meneghello
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

9.  Cardiovascular Risk in Psoriasis Patients: Clinical, Functional and Morphological Parameters.

Authors:  Angélica Navarro de Oliveira; Marcela M Simões; Ricardo Simões; Marcus Vinicius Bolivar Malachias; Bruno Almeida Rezende
Journal:  Arq Bras Cardiol       Date:  2019-07-18       Impact factor: 2.000

Review 10.  Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis.

Authors:  Siddharth Singh; Antonio Facciorusso; Abha G Singh; Niels Vande Casteele; Amir Zarrinpar; Larry J Prokop; Eduardo L Grunvald; Jeffrey R Curtis; William J Sandborn
Journal:  PLoS One       Date:  2018-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.